IL17A and neoplasm: We found that the blockade of IL-17 with the antibody prevented BMMCs-mediated MDSC infiltration to tumor and decreased the suppressive activity of MDSCs (Fig. 2, A and B), suggesting that mast cells regulate MDSCs through IL-17 pathway.